GlaxoSmithKline (GSK) agrees to sell 25 older drugs marketed in Australia to South Africa's...


GlaxoSmithKline (GSK) agrees to sell 25 older drugs marketed in Australia to South Africa's Aspen Pharmacare for £172M as GSK continues its divestment of non-core treatments. The deal follows three divestitures within GSK's non-prescription division over the past several months.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs